pemetrexed,cisplatin,gemcitabine,pembrolizumab
merck
['keynote,671', 'breast', 'lung', 'melanoma', 'lcsm,(-blcsm)', 'keynote-671']
ready for #asco23 day 2, neadyuvant immunotherapy key trials in lung, melanoma and breast cancer! starting with keynote-671 and discussion by in hall d1! #lcsm 
MD, PhD - Thoracic Oncologist. Precision Medicine Consultant & Co-Founder PxMedica and Medical Consultant @bradfordhill_cl.